Literature DB >> 33859784

Androgen Receptor Degradation for Therapeutic Intervention of Prostate Cancer Drug Resistance.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2021        PMID： 33859784      PMCID： PMC8040041          DOI： 10.1021/acsmedchemlett.1c00120

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Advances in the computational development of androgen receptor antagonists.

Authors:  Xueping Hu; Xin Chai; Xuwen Wang; Mojie Duan; Jinping Pang; Weitao Fu; Dan Li; Tingjun Hou
Journal:  Drug Discov Today       Date:  2020-05-18       Impact factor: 7.851

Review 2.  Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications.

Authors:  Chiara Pisano; Marcello Tucci; Rosario Francesco Di Stefano; Fabio Turco; Giorgio Vittorio Scagliotti; Massimo Di Maio; Consuelo Buttigliero
Journal:  Crit Rev Oncol Hematol       Date:  2020-11-27       Impact factor: 6.312

Review 3.  Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer.

Authors:  Samanta Salvi; Massimiliano Bonafè; Sara Bravaccini
Journal:  Semin Cancer Biol       Date:  2019-04-16       Impact factor: 15.707

4.  A critical update on the strategies towards modulators targeting androgen receptors.

Authors:  Hongyu Luan; Pengfei Xu; Ying Meng; Zhiyu Li; Jinlei Bian
Journal:  Bioorg Med Chem       Date:  2020-05-12       Impact factor: 3.641

Review 5.  A novel GPCR target in correlation with androgen deprivation therapy for prostate cancer drug discovery.

Authors:  Jing-Yan Tian; Chang-Liang Chi; Ge Bian; Feng-Jun Guo; Xiao-Qing Wang; Bing Yu
Journal:  Basic Clin Pharmacol Toxicol       Date:  2020-12-01       Impact factor: 4.080

Review 6.  Loss and revival of androgen receptor signaling in advanced prostate cancer.

Authors:  Nicolò Formaggio; Mark A Rubin; Jean-Philippe Theurillat
Journal:  Oncogene       Date:  2021-01-08       Impact factor: 9.867
  6 in total
  1 in total

Review 1.  Targeting Oncoproteins for Degradation by Small Molecule-Based Proteolysis-Targeting Chimeras (PROTACs) in Sex Hormone-Dependent Cancers.

Authors:  Li Liu; Lihong Shi; Zhaodi Wang; Jun Zeng; Yue Wang; Hongtao Xiao; Yongxia Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-18       Impact factor: 5.555
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.